Sean Dodge
Stock Analyst at RBC Capital
(2.10)
# 2,684
Out of 4,820 analysts
133
Total ratings
32.29%
Success rate
-3.75%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $4.10 | +46.34% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $3.89 | -9.91% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $150.34 | +79.59% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.20 | +66.67% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $144.90 | +81.50% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.98 | +89.31% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $24.75 | +29.29% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $8.65 | -30.64% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $85.87 | +22.28% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $11.16 | +52.40% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $37.02 | -8.16% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $25.38 | -44.84% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.67 | +114.13% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $23.16 | +20.90% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $13.67 | +2.41% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $163.28 | -79.79% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.46 | +12,228.77% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $4.10
Upside: +46.34%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $3.89
Upside: -9.91%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $150.34
Upside: +79.59%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.20
Upside: +66.67%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $144.90
Upside: +81.50%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.98
Upside: +89.31%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $24.75
Upside: +29.29%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $8.65
Upside: -30.64%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $85.87
Upside: +22.28%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $11.16
Upside: +52.40%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $37.02
Upside: -8.16%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $25.38
Upside: -44.84%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.67
Upside: +114.13%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $23.16
Upside: +20.90%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $13.67
Upside: +2.41%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $163.28
Upside: -79.79%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.46
Upside: +12,228.77%